Clinical Trials Logo

MDS-EB-1 clinical trials

View clinical trials related to MDS-EB-1.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04636918 Recruiting - Clinical trials for Leukemia (Both ALL and AML)

Ikervis for DED Due to GVHD Post Allo-HSCT

Ikervis
Start date: November 28, 2019
Phase: Phase 4
Study type: Interventional

Dry eye disease (DED) is a common sequelae of graft versus host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Since Ikervis is reported to be a safe and efficacious treatment of DED associated with chronic GVHD, our study would like to study the efficacy of prophlactic Ikervis in preventing ocular GVHD development.